12th Annual IBA World Life Sciences Conference
3 Jun - 5 Jun 2026
Session information
Description
- Collaboration and licensing structures as financing tools
- The new frontiers of telemedicine
- Cross-border investment constraints affecting financings and exits (CFIUS risk, sensitive health/genomic data, and closing conditions)
- Cooperations between and vertical integration of pharma/medtech and hospitals/clinics/pharmacies etc [SF1.1]
- GLP‑1s: are legal frameworks keeping pace with the weight‑loss revolution?
- Resolving international patent licensing disputes by arbitration – recurring issues and new developments
- Liability and accountability in open science research
- The future of supplementary protection: are SPCs still fit for purpose?
- Advertising, labelling and influencer promotion of medicinal products
- Combination products (drug-device) regulation
- Causes and consequences of ‘medical device and drugs lag’
- Whistleblower actions and anti-fraud enforcement trends in the healthcare industry
- When pharmaceutical patent enforcement leads to damages – for either side
- Pricing of medicines: an international perspective
- Ethical and legal challenges of human genome editing
Speakers
| Andrea Abascal | Bofill Mir Abogados, Santiago, Chile; Conference Quality Officer, Healthcare and Life Sciences Law Committee |
| Joana Botelho | Cuatrecasas, Lisbon, Portugal |
| Gustaf Duhs | Stevens & Bolton, Guildford, England |
| Jordi Faus | Faus & Moliner Abogados SLP, Barcelona, Spain |
| Francisco Javier García Pérez | Uria Menendez, Barcelona, Spain |
| Monika Gattiker | DGS Rechtsanwälte Steuerexperten, Zürich, Switzerland; Treasurer, Healthcare and Life Sciences Law Committee |
| Philipp Groz | Schellenberg Wittmer, Zürich, Switzerland |
| Tímea Halkó | Gedeon Richter, Budapest, Hungary |
| Yuval Horn | Gornitzky & Co, Tel Aviv, Israel; Member, Technology Law Committee Advisory Board |
| Joanna Krakowiak | Wardynski & Partners, Warsaw, Poland |
| Jose Alejandro Luna Fandino | Olivares, Mexico City, Mexico |
| Sir Guilherme Mendonça | Coloplast, São Paulo, Brazil |
| Hugo Monteiro de Queirós | PLMJ, Lisbon, Portugal |
| Jackie Mulryne | Morgan Lewis, London, England |
| Sean Murray | Knobbe Martens Olson and Bear LLP, Irvine, California, USA |
| Ricardo Nascimento Ferreira | Morais Leitão, Lisbon, Portugal |
| Matthias Nordmann | SKW Schwarz , Munich, Germany |
| Adeniji Oni | Niji Oni & Co, Lagos, Nigeria; Senior Vice Chair, Agriculture and Food Section |
| Francisca Paulouro | VdA Vieira de Almeida, Lisbon, Portugal |
| Leonor Pissarra | SRS Legal, Lisbon, Portugal |
| Elysangela Rabelo | Demarest Advogados, São Paulo, Brazil; Chair, Life Sciences Subcommittee |
| Ioana Ratescu | Novartis Pharma AG, Basel, Switzerland |
| Janine Reudt-Demont | Niederer Kraft Frey AG, Zürich, Switzerland; Social Media and Website Officer, Healthcare and Life Sciences Law Committee |
| Anderson Ribeiro | Souto Correa Advogados, São Paulo, Brazil; Scholarship Officer, Healthcare and Life Sciences Law Committee |
| Markus Schott | Baer & Karrer, Zürich, Switzerland; Vice Chair, Healthcare and Life Sciences Law Committee |
| Christopher Stovin | Incyte Biosciences International Sàrl, Morges, Switzerland |
| Koen T'Syen | Van Bael & Bellis, Brussels, Belgium |
| Lincoln Tsang | Ropes & Gray LLP, London, England |
| Tess Waldron | Powell Gilbert LLP, London, England |
| Conna Weiner | Conna Weiner ADR, Boston, Massachusetts, USA |
| Milena Yakimova | Baxter International , Sofia, Bulgaria |